Non-Small Cell Lung Cancer-Tumor Biology
Mumtaz V Rojiani1,2,3, Amyn M Rojiani1,2
1Department of Pathology, Penn State College of Medicine, Hershey, PA 17033, USA.
Cancers
|February 24, 2024
Summary
Lung cancer remains a major global health concern, causing significant mortality in both men and women. Early detection and effective treatments are crucial for improving patient outcomes and reducing the impact of this disease.
Area of Science:
- Oncology
- Pulmonology
- Public Health
Background:
- Lung cancer represents a critical global health challenge, contributing significantly to cancer-related deaths worldwide.
- The disease affects both men and women, underscoring the need for broad-reaching prevention and treatment strategies.
Discussion:
- Investigating the multifaceted nature of lung cancer is essential for understanding its epidemiology and impact.
- Developing innovative therapeutic approaches and enhancing early diagnostic methods are paramount.
Key Insights:
- Lung cancer is a leading cause of mortality globally.
- The disease impacts both genders, necessitating comprehensive research and intervention.
- Further research is vital for advancing treatment and prevention.
Outlook:
- Continued research into lung cancer pathogenesis and treatment is expected to yield improved survival rates.
- Public health initiatives focusing on smoking cessation and early screening can mitigate lung cancer incidence.
- Advancements in personalized medicine hold promise for more effective lung cancer management.
Related Concept Videos
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K